Damora Therapeutics is trading at $21.23, down 5.29%, amid broader risk-off trading.
- On September 23, 2026, the Nasdaq Composite was down 1.10% and the S&P 500 was down 0.55%.
- No new company-specific announcement was identified for September 23; the latest listed investor-relations release was September 3 inducement grants.
- Higher oil prices and Treasury yields are adding pressure to equity valuations.